Lv3
210 积分 2023-11-22 加入
Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults
4小时前
已完结
Safety evaluation of bempedoic acid: A pharmacovigilance analysis using FDA adverse event reporting system data
3天前
已完结
Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study
12天前
已完结
Mining of adverse event signals associated with inclisiran: a post-marketing analysis based on FAERS
24天前
已完结
Postmarketing Reports of Incomplete Dosing-Related Complications with Self-Injected PCSK9 Inhibitors: A Descriptive Study and Disproportionality Analysis
2个月前
已完结
Post-marketing pharmacovigilance study of inclisiran: mining and analyzing adverse event data from the FDA Adverse Event Reporting System database
2个月前
已完结
Adverse events associated with inclisiran: a real-world disproportionality analysis based on the FAERS database
2个月前
已完结
Analysis of Inclisiran in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and Sex-specific Subgroups
4个月前
已完结
Inclisiran
6个月前
已关闭
Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials
6个月前
已完结
皖公网安备34019202002308
